Graham BS - Search Results

1

Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate.

Liang B, Ngwuta JO, Surman S, Kabatova B, Liu X, Lingemann M, Liu X, Yang L, Herbert R, Swerczek J, Chen M, Moin SM, Kumar A, McLellan JS, Kwong PD, Graham BS, Collins PL, Munir S. Liang B, et al. Among authors: graham bs. J Virol. 2017 Jul 12;91(15):e00189-17. doi: 10.1128/JVI.00189-17. Print 2017 Aug 1. J Virol. 2017. PMID: 28539444 Free PMC article.

2

Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine.

Johnson TR, Fischer JE, Graham BS. Johnson TR, et al. Among authors: graham bs. J Gen Virol. 2001 Sep;82(Pt 9):2107-2116. doi: 10.1099/0022-1317-82-9-2107. J Gen Virol. 2001. PMID: 11514719

3

NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus.

Johnson TR, Hong S, Van Kaer L, Koezuka Y, Graham BS. Johnson TR, et al. Among authors: graham bs. J Virol. 2002 May;76(9):4294-303. doi: 10.1128/jvi.76.9.4294-4303.2002. J Virol. 2002. PMID: 11932395 Free PMC article.

4

Respiratory syncytial virus immunobiology and pathogenesis.

Graham BS, Rutigliano JA, Johnson TR. Graham BS, et al. Virology. 2002 May 25;297(1):1-7. doi: 10.1006/viro.2002.1431. Virology. 2002. PMID: 12083830 Free article. Review. No abstract available.

5

Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formation.

McCurdy LH, Graham BS. McCurdy LH, et al. Among authors: graham bs. J Virol. 2003 Feb;77(3):1747-56. doi: 10.1128/jvi.77.3.1747-1756.2003. J Virol. 2003. PMID: 12525608 Free PMC article.

6

IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge.

Johnson TR, Parker RA, Johnson JE, Graham BS. Johnson TR, et al. Among authors: graham bs. J Immunol. 2003 Feb 15;170(4):2037-45. doi: 10.4049/jimmunol.170.4.2037. J Immunol. 2003. PMID: 12574374

7

Treatment with anti-LFA-1 delays the CD8+ cytotoxic-T-lymphocyte response and viral clearance in mice with primary respiratory syncytial virus infection.

Rutigliano JA, Johnson TR, Hollinger TN, Fischer JE, Aung S, Graham BS. Rutigliano JA, et al. Among authors: graham bs. J Virol. 2004 Mar;78(6):3014-23. doi: 10.1128/jvi.78.6.3014-3023.2004. J Virol. 2004. PMID: 14990720 Free PMC article.

8

Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV.

Johnson TR, Teng MN, Collins PL, Graham BS. Johnson TR, et al. Among authors: graham bs. J Virol. 2004 Jun;78(11):6024-32. doi: 10.1128/JVI.78.11.6024-6032.2004. J Virol. 2004. PMID: 15141000 Free PMC article.

9

Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV.

Johnson TR, Varga SM, Braciale TJ, Graham BS. Johnson TR, et al. Among authors: graham bs. J Virol. 2004 Aug;78(16):8753-60. doi: 10.1128/JVI.78.16.8753-8760.2004. J Virol. 2004. PMID: 15280483 Free PMC article.

10

Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection.

Rutigliano JA, Graham BS. Rutigliano JA, et al. Among authors: graham bs. J Immunol. 2004 Sep 1;173(5):3408-17. doi: 10.4049/jimmunol.173.5.3408. J Immunol. 2004. PMID: 15322205

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

587 results

Search Page

Filters